ADTX Scorecard | Aditxt, Inc.

Aditxt, Inc. (ADTX) Scorecard

2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.

40 QUARTERS × 3 ROAST BATTLES

12/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q20/3	LoseADTX / S&P -99.98% / 15.20%	LoseADTX / S&P ADTX unavailable / 15.00%	LoseADTX / S&P ADTX unavailable / 50.40%
2026-Q10/3	LoseADTX / S&P -85.34% / -4.33%	LoseADTX / S&P -74.09% / 11.30%	LoseADTX / S&P -99.99% / 27.70%
2025-Q40/3	LoseADTX / S&P -99.02% / 2.65%	LoseADTX / S&P -97.62% / 9.00%	LoseADTX / S&P -98.13% / 13.40%
2025-Q31/3	LoseADTX / S&P -41.25% / 8.12%	LoseADTX / S&P -97.20% / 4.61%	WinADTX / S&P 132.96% / 13.45%
2025-Q21/3	LoseADTX / S&P -71.46% / 10.94%	LoseADTX / S&P -96.35% / 4.83%	WinADTX / S&P 9134.91% / 10.63%
2025-Q11/3	LoseADTX / S&P -90.56% / -4.27%	LoseADTX / S&P -89.08% / 4.98%	WinADTX / S&P 9216.96% / 10.57%
2024-Q41/3	LoseADTX / S&P -95.56% / 2.41%	LoseADTX / S&P -79.23% / 5.25%	WinADTX / S&P 44842.27% / 6.15%
2024-Q31/3	LoseADTX / S&P -92.19% / 5.89%	LoseADTX / S&P -71.70% / 5.89%	WinADTX / S&P 169682.50% / 6.11%
2024-Q21/3	LoseADTX / S&P -59.71% / 4.28%	LoseADTX / S&P -65.22% / 5.38%	WinADTX / S&P 66097.65% / 5.12%
2024-Q11/3	LoseADTX / S&P -48.72% / 10.56%	LoseADTX / S&P -46.23% / 5.71%	WinADTX / S&P 79278.54% / 5.59%
2023-Q41/3	LoseADTX / S&P -46.92% / 11.69%	LoseADTX / S&P -30.90% / 6.81%	WinADTX / S&P 23691.12% / 7.78%
2023-Q31/3	LoseADTX / S&P -30.61% / -3.27%	LoseADTX / S&P ADTX unavailable / 7.52%	WinADTX / S&P 603.49% / -5.03%
2023-Q21/3	LoseADTX / S&P -50.60% / 8.74%	LoseADTX / S&P ADTX unavailable / 9.50%	WinADTX / S&P 96.01% / -8.57%
2023-Q11/3	LoseADTX / S&P -21.13% / 7.50%	LoseADTX / S&P ADTX unavailable / 10.77%	WinADTX / S&P 73.69% / -15.69%
2022-Q40/3	LoseADTX / S&P -65.93% / 7.56%	LoseADTX / S&P ADTX unavailable / 11.88%	LoseADTX / S&P ADTX unavailable / -17.99%
2022-Q30/3	LoseADTX / S&P -52.59% / -4.88%	LoseADTX / S&P ADTX unavailable / 13.47%	LoseADTX / S&P ADTX unavailable / -1.41%
2022-Q20/3	LoseADTX / S&P -68.71% / -16.10%	LoseADTX / S&P ADTX unavailable / 13.71%	LoseADTX / S&P ADTX unavailable / 11.04%
2022-Q10/3	LoseADTX / S&P -14.74% / -4.60%	LoseADTX / S&P ADTX unavailable / 15.97%	LoseADTX / S&P ADTX unavailable / 42.23%
2021-Q40/3	LoseADTX / S&P -68.28% / 11.03%	LoseADTX / S&P ADTX unavailable / 15.00%	LoseADTX / S&P ADTX unavailable / 96.40%
2021-Q30/3	LoseADTX / S&P -34.75% / 0.58%	LoseADTX / S&P ADTX unavailable / 10.77%	LoseADTX / S&P ADTX unavailable / 69.42%
2021-Q20/3	LoseADTX / S&P 1.57% / 8.55%	LoseADTX / S&P ADTX unavailable / 6.58%	LoseADTX / S&P ADTX unavailable / 51.81%
2021-Q11/3	WinADTX / S&P 22.60% / 6.17%	LoseADTX / S&P ADTX unavailable / -1.06%	LoseADTX / S&P ADTX unavailable / 7.39%
2020-Q40/3	LoseADTX / S&P 6.67% / 12.15%	LoseADTX / S&P ADTX unavailable / -3.72%	LoseADTX / S&P ADTX unavailable / -33.42%
2020-Q30/3	LoseADTX / S&P -61.46% / 8.93%	LoseADTX / S&P ADTX unavailable / -2.04%	LoseADTX / S&P ADTX unavailable / -27.10%
2020-Q20/3	LoseADTX / S&P ADTX unavailable / 20.54%	LoseADTX / S&P ADTX unavailable / -0.46%	LoseADTX / S&P ADTX unavailable / -27.11%
2020-Q10/3	LoseADTX / S&P ADTX unavailable / -19.60%	LoseADTX / S&P ADTX unavailable / 3.47%	LoseADTX / S&P ADTX unavailable / -14.75%
2019-Q40/3	LoseADTX / S&P ADTX unavailable / 9.07%	LoseADTX / S&P ADTX unavailable / 5.36%	LoseADTX / S&P ADTX unavailable / 2.99%
2019-Q30/3	LoseADTX / S&P ADTX unavailable / 1.70%	LoseADTX / S&P ADTX unavailable / 5.02%	LoseADTX / S&P ADTX unavailable / 0.21%
2019-Q20/3	LoseADTX / S&P ADTX unavailable / 4.30%	LoseADTX / S&P ADTX unavailable / 6.64%	LoseADTX / S&P ADTX unavailable / 8.65%
2019-Q10/3	LoseADTX / S&P ADTX unavailable / 13.65%	LoseADTX / S&P ADTX unavailable / 8.12%	LoseADTX / S&P ADTX unavailable / 14.29%
2018-Q40/3	LoseADTX / S&P ADTX unavailable / -13.52%	LoseADTX / S&P ADTX unavailable / 9.05%	LoseADTX / S&P ADTX unavailable / 18.23%
2018-Q30/3	LoseADTX / S&P ADTX unavailable / 7.71%	LoseADTX / S&P ADTX unavailable / 10.21%	LoseADTX / S&P ADTX unavailable / 19.06%
2018-Q20/3	LoseADTX / S&P ADTX unavailable / 3.43%	LoseADTX / S&P ADTX unavailable / 9.03%	LoseADTX / S&P ADTX unavailable / 14.46%
2018-Q10/3	LoseADTX / S&P ADTX unavailable / -0.76%	LoseADTX / S&P ADTX unavailable / 7.68%	LoseADTX / S&P ADTX unavailable / 12.46%
2017-Q40/3	LoseADTX / S&P ADTX unavailable / 6.64%	LoseADTX / S&P ADTX unavailable / 7.03%	LoseADTX / S&P ADTX unavailable / 13.82%
2017-Q30/3	LoseADTX / S&P ADTX unavailable / 4.48%	LoseADTX / S&P ADTX unavailable / 5.68%	LoseADTX / S&P ADTX unavailable / 17.57%
2017-Q20/3	LoseADTX / S&P ADTX unavailable / 3.09%	LoseADTX / S&P ADTX unavailable / 4.83%	LoseADTX / S&P ADTX unavailable / 17.74%
2017-Q10/3	LoseADTX / S&P ADTX unavailable / 6.07%	LoseADTX / S&P ADTX unavailable / 3.67%	LoseADTX / S&P ADTX unavailable / 13.32%
2016-Q40/3	LoseADTX / S&P ADTX unavailable / 3.82%	LoseADTX / S&P ADTX unavailable / 2.09%	LoseADTX / S&P ADTX unavailable / 7.05%
2016-Q30/3	LoseADTX / S&P ADTX unavailable / 3.85%	LoseADTX / S&P ADTX unavailable / 0.20%	LoseADTX / S&P ADTX unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	ADTX total return	S&P 500 Total Return Index
Total return	-100.00%	20.78%
Annualized return	-100.00%	20.78%

5Y · 2021-09-01 to 2026-08-27

Metric	ADTX total return	S&P 500 Total Return Index
Total return	-100.00%	83.14%
Annualized return	-99.85%	12.86%

10Y · 2020-06-30 to 2026-08-27

Metric	ADTX total return	S&P 500 Total Return Index
Total return	-100.00%	319.30%
Annualized return	-96.54%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Rafael Holdings, Inc. (RFL)	United States	$0.000B	-0.00
CDT Equity Inc. (CDT)	United States	$0.000B	-0.01
Protagenic Therapeutics, Inc.\new (PTIX)	United States	$0.001B
Decoy Therapeutics Inc. (DCOY)	United States	$0.002B	-0.27
Nexentis Technologies Inc. (NXTS)		$0.002B
ORAGENICS INC (OGEN)	United States	$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)	United States	$0.002B	-0.02
BioXcel Therapeutics, Inc. (BTAI)	United States	$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)	United States	$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)	United States	$0.003B